Delivery Order 75N93019D00022-75N93020F00001

Award Date 5/18/20
Potential Completion Date 5/17/21
Potential Value $115K
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Antonio, TX 78229, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The University of Texas Health Science Center of San Antonio was awarded a $99,854.52 delivery order against the In Vitro Assessments of Antimicrobial Activity (IVAAA) master IDIQ contract by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. The firm fixed price order is to provide in vitro assessments of antimicrobial activity, as outlined in the IVAAA vehicle's original solicitation, with performance taking place...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $126,264 firm fixed price delivery order to the University of Texas Health Science Center of San Antonio under the In Vitro Assessments of Antimicrobial Activity indefinite-delivery/indefinite-quantity multiple award contract vehicle. This task order is for the determination of the in vitro inhibitory effect of experimental antibacterial substances against the...
The University of Texas Health Science Center of San Antonio was awarded a $106,558 firm fixed price delivery order against the In Vitro Assessments of Antimicrobial Activity (IVAAA) master indefinite-delivery/indefinite-quantity contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this contract, the University will determine the in vitro inhibitory effect of experimental antifungal substances against fungal pathogens. The work will be...
The University of Texas Health Science Center of San Antonio was awarded a $115,162 firm fixed price delivery order against the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases' In Vitro Assessments of Antimicrobial Activity indefinite-delivery/indefinite-quantity contract. The one-year order is to perform in vitro screening for antifungal activity against fungal disease pathogens in support of NIH/NIAID infectious...
The University of Texas Health Science Center of San Antonio was awarded a $146,780 firm fixed price delivery order against the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases' In Vitro Assessments of Antimicrobial Activity indefinite-delivery/indefinite-quantity contract. The delivery order is to perform in vitro screening for antifungal activity against fungal disease pathogens. As the prime contractor, the...
The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $218,715.00 Firm Fixed Price delivery order contract to the University of Texas Health Science Center at San Antonio (UTHSCSA) for in vitro testing related to antimicrobial resistant antibacterial activity. This order is part of the larger "In Vitro Antimicrobial Assessments 2011-2018" Indefinite Delivery Contract, which has no set-aside...
This is a $144,060.28 firm fixed price delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to the University of Texas Health Science Center at San Antonio (UTHSCSA). The contract is for in vitro assessment of antimicrobial activity and spans one year from May 16, 2018 to May 15, 2019. It is a task order under the larger In Vitro Antimicrobial Assessments 2011-2018 IDIQ contract. UTHSCSA...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $208,965.00 firm fixed price delivery order to the University of Texas Health Science Center at San Antonio (UTHSCSA) to provide in vitro assessment for antimicrobial activity. This task order is part of a larger 7-year, $146.3 million indefinite delivery contract between NIAID and UTHSCSA to develop and refine small animal, non-human primate, and non-traditional animal models for evaluating candidate therapeutics and...
This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to The University of Texas Health Science Center at San Antonio (UTHSCSA). The contract, valued at $83,272.33, is for in vitro assessment of antimicrobial activity under the larger In Vitro Antimicrobial Assessments 2011-2018 indefinite delivery vehicle. UTHSCSA, as a subcomponent of the University of Texas...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Texas Health Science Center at San Antonio (UTHSCSA) as a delivery order under the "In Vitro Antimicrobial Assessments 2011-2018" indefinite delivery vehicle (IDV). The fixed-price contract has a ceiling value of $100,723.00 and is for in vitro assessment of antimicrobial activity. As a state-controlled institution of higher learning, UTHSCSA has a history of...

The University of Texas Health Science Center of San Antonio was awarded a $114,565 firm fixed price delivery order against the In Vitro Assessments of Antimicrobial Activity (IVAAA) master IDIQ contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The delivery order calls for the prime contractor to determine the in vitro inhibitory effect of experimental antibacterial substances against bacterial species identified in the statement of work using MIC and MIC 90 testing methods. Work will be performed in San Antonio, Texas over a one year period ending in May 2021. The contract supports the NIH/NIAID's research into evaluating potential new treatments for infectious diseases.

Generated 12/30/23, 9:05 PM